Davidson

Davidson Pharma is a specialized pharmaceutical company based in Berlin, Germany, that focuses on the development, registration, and distribution of niche products and orphan drugs. The company addresses therapeutic gaps in rare diseases and specialized medical conditions, ensuring the supply of essential medications that larger pharmaceutical firms may overlook. Their core portfolio includes D-penicillamine, a chelating agent used for Wilson's disease, cystinuria, and heavy metal poisoning. Davidson Pharma operates with a lean structure, prioritizing high-quality manufacturing and reliable distribution within the European healthcare system.